Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Oncoceutics Inc aggregated by PharmaCompass.com.

    Client Virtual Booth

    ONCOCEUTICS INC

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Oncoceutics Inc
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3624 Market Street University City Science Center, Suite 5E Philadelphia, PA 19104
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://oncoceutics.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Oncoceutics Receives Foundation Grants to Establish an Expanded Access
    Oncoceutics Receives Foundation Grants to Establish an Expanded Access

    https://oncoceutics.com/oncoceutics-receives-foundation-grants-to-establish-an-expanded-access-program-for-onc201/#:~:text=Philadelphia%2C%20PA%20(November%205%2C,ONC201%20in%20the%20United%20States.

    PRESS RELEASE
    09 Nov 2020
    Share Share
    Oncoceutics Begins Trial with Next-Generation Imipridone ONC206
    Oncoceutics Begins Trial with Next-Generation Imipridone ONC206

    https://oncoceutics.com/oncoceutics-begins-clinical-trial-with-next-generation-imipridone-onc206-at-the-nih/

    PRESS RELEASE
    28 Oct 2020
    Share Share
    Oncoceutics Expands IP Portfolio With Additional Patents for ONC201 and ONC212
    Oncoceutics Expands IP Portfolio With Additional Patents for ONC201 and ONC212

    https://oncoceutics.com/oncoceutics-expands-ip-portfolio-with-additional-patents-for-onc201-and-onc212/

    PRESS RELEASE
    13 Oct 2020
    Share Share
    Oncoceutics to Present Additional Data at ASCO Showing Clinical Benefit ONC201
    Oncoceutics to Present Additional Data at ASCO Showing Clinical Benefit ONC201

    https://oncoceutics.com/oncoceutics-to-present-additional-data-at-asco-showing-clinical-benefit-from-onc201-for-cancer-patients/

    ONCOCEUTICS
    30 May 2020
    Share Share
    Phase I/II Clinical Study of ONC201 Begins in Japan
    Phase I/II Clinical Study of ONC201 Begins in Japan

    https://oncoceutics.com/phase-i-ii-clinical-study-of-onc201-begins-in-japan/

    ONCOCEUTICS
    01 Apr 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search